Business
Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with cats – The Guardian
GS-441524 has been used to treat a coronavirus in cats but activists accuse company of pushing remdesivir to boost profit
Activists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus.
The drug, called GS-441524, is chemically related to remdesivir, an antiviral also made by Gilead, and one of the only treatments to successfully shorten the duration of Covid-19 recovery.
GS-441524 has also attracted attention for its promise to treat another potential coronavirus feline infectious peritonitis, or FIP. The drug has…
-
General20 hours agoRestaurants on the brink as business failures plateau
-
General9 hours agoThree maps that show the scale of the NSW flood disaster
-
General23 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General20 hours agoRegional house price growth outstrips capital cities